Sumanta Kumar Pal, MD | Authors

Articles

Sequencing Abiraterone and Enzalutamide in mCRPC

February 20, 2014

Sumanta Kumar Pal, MD, assistant professor, genitourinary cancers, City of Hope, discusses sequencing abiraterone and enzalutamide for the treatment of metastatic castration-resistant prostate cancer (mCRPC).